GlassScriptPhysician profile
Danika Lea Paulo
NPI 1477085801
$44,636.73
in general payments reported to CMS, 2019-2025
6 companies · $6,287 in 2025
The $6,287 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $38K · 2025: $6,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $35K · Travel and Lodging: $3,634 · Food and Beverage: $3,503 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $35,000.00 |
| Travel and Lodging | $3,634.22 |
| Food and Beverage | $3,502.51 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,145.95 | 2024-2025 | Activa PC, Percept PC Brainsense, Inceptiv |
| Boston Scientific Corporation | $16,901.38 | 2024-2025 | Vercise, General - Dbs, Bionic Navigator |
| Koh Young America, INC. | $4,022.83 | 2025 | Geniant Cranial |
| Zimmer Biomet Holdings, INC. | $313.76 | 2025 | Rosa |
| Globus Medical, INC. | $167.97 | 2025 | Senza |
| Abbott Laboratories | $84.84 | 2025 | Infinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danika Paulo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.